Arenal Del Adrian

Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom.

Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne.

Part of Smith & Nephew plc, T.J. Smith & Nephew Ltd. is a British company that manufactures healthcare products. The company is based in Hull, UK. The company was founded in 1907. T.J. Smith & Nephew was acquired by Robinson Healthcare Group Ltd. from Smith & Nephew plc on July 01, 1999 for $22.60 million.

Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France.

NeuroSolutions Ltd. provides flexible and skilled services to biopharmaceutical companies with a fast turnaround time. The private company is based in Coventry, UK. The British company has a large portfolio of clients, ranging from small start-ups to multinational pharmaceutical companies, which validates their quality, reliability, speed, and discretion. The company was founded by Kevin Lee. NeuroSolutions was acquired by NeuroSolutions /Private Group/ from OncoSil Medical Ltd. on August 11, 2010 for $0.72 million.

Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands.

Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom.

Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD.

Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark.

Cyclofluidic Ltd. is a British private company. The firm operates proprietary microfluidic drug discovery platform.

Part of Smith & Nephew plc, Smith & Nephew Extruded Films Ltd. operates as a British non-trading company. The company is based in East Yorkshire, UK.

Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom.

Part of Premier Technical Services Group Ltd., PTSG Access & Safety Ltd. is a building access specialist based in Castleford, UK. PTSG Access & Safety provides solutions to the most challenging buildings through their highly trained access specialists. The British company offers a range of services including the design, installation, testing, and certification of critical access and safety equipment and systems. The company was founded in 2007. Roger Peter Teasdale has been the CEO of the company since 2014.

Part of Premier Technical Services Group Ltd., Brooke Edgley Specialist Technical Services Ltd. is a British company that specializes in earthing and lightning protection services. The company was founded in 1957 and is based in Castleford, UK. The company offers services such as earthing design, installation, and commissioning of new systems, soil resistivity surveys, and earth resistance measurement. Additionally, they provide lightning protection services including installations, site surveys, system alterations, and lightning protection system inspection, testing, and maintenance. The company is committed to providing excellent customer service from initial enquiry to ongoing maintenance. For more information about their lightning and surge protection experience, visit their website.

Nimbus Lightning Protection Ltd. designs, install, and maintain lightning protection and specialize earthing systems. Its services include rope access, strike risk management, specialist welding, testing and maintenance, surge protection, and lighting protection. The company was founded on November 2007 and is headquartered in Lambley, the United Kingdom.

Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway.

Bernard Bidco Ltd. operates as an investment company. The company was founded on May 02, 2019 and is headquartered in Castleford, the United Kingdom.

Part of Macquarie Group Ltd., Bernard Midco Ltd. is an investment holding British company. The company is based in Castleford, UK. Founded in 2019, Bernard Midco functions as an investment holding company.

Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019.

Spliceor Ltd. is a British company founded in 2020 that specializes in gene therapies for aggressive cancers. The company is based in Cambridge, UK. The company's website is currently under construction, but more details are expected to follow.

Part of Smith & Nephew plc, Smith & Nephew Medical Ltd. is a British company that supplies medical equipment. The company is based in Hull, UK and was founded in 1958.

Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom.